from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2vpN4uh on August 11, 2017 at 04:14PM
PM360 sat with 10 industry professionals to discuss how the health care industry will change over the course of the next five years.
IM HealthScience Chairman Fred Hassan, Frontline MedCom Vice President of Marketing and Customer Advocacy Jim McDonough, Context Matters Founder and CEO Dr. Yin Ho were among the industry leaders interviewed.
Questions asked included:
- “What will be the impact on innovation in drug development in terms of new treatments and pipelines for new drugs? How will that affect time-to-market for new drugs and treatments? Which therapeutic areas will see the biggest growth over this time?”
- “What does pharma expect from the new administration in terms of prescription pricing, and how will that affect not only bottom line, but also patient access to treatment? How would access constraints affect the industry and what could the pharmaceutical industry do to address this?”
- “How might the pharma/payer dynamic change in this new climate?”